MEDRAD and GE Healthcare have announced the availability of an endorectal coil for 3.0T magnetic resonance (MR) prostate imaging. The MEDRAD 3.0T Prostate eCoil is available for GE Signa HDx 3.0T MR scanners. The eCoil is designed to enable personalized treatment planning that may reduce significant side effects of prostate cancer treatment, the companies said.
MEDRAD designed the 3.0T Prostate eCoil to produce very accurate diagnostic images of the prostate that may enable early diagnosis and staging of prostate cancer. The 3.0T Prostate eCoil also can be used to plan radiation therapy in a way that helps physicians localize treatment to only the affected part of the gland. By giving clinicians more accurate images for use in planning and delivering targeted treatment, the eCoil may help them personalize the patient’s treatment.
The eCoil balloon conforms to the size and shape of the prostate for consistent contact between the gland and the signal-amplifying elements of the coil. The result is small field-of-view (FOV) and high spatial resolution, sensitivity, and specificity for clearer pictures of the prostate.
“Prostate cancer strikes over 200,000 men annually, and we believe the prostate eCoil can help in the diagnosis and treatment of this disease,” said MEDRAD’s Gary Bucciarelli, senior vice president, Magnetic Resonance Business Unit. “It will provide urologists, radiologists, and radiation oncologists with better information for treatment planning, recognizing that each patient is unique and that their treatment for prostate cancer should be as well.”
“GE Healthcare has made a commitment to aggressively pursue the development of MR technology for the assessment of prostate disease,” said GE’s John Chiminski, vice president and general manager, Global Magnetic Resonance business. “The availability of the MEDRAD 3.0T eCoil on the GE 3.0T HDx scanner strengthens our clinical roadmap.”
The Prostate eCoil is also available for 1.5T magnet strength systems.